Evolent Health, Inc. (FRA:9EH)

Germany flag Germany · Delayed Price · Currency is EUR
3.320
+0.020 (0.61%)
At close: Dec 4, 2025
-72.56%
Market Cap 383.75M
Revenue (ttm) 1.75B
Net Income (ttm) -154.17M
Shares Out n/a
EPS (ttm) -1.34
PE Ratio n/a
Forward PE 16.42
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 348
Open 3.320
Previous Close 3.300
Day's Range 3.320 - 3.320
52-Week Range 3.120 - 12.200
Beta n/a
RSI 28.92
Earnings Date Feb 27, 2026

About Evolent Health

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workf... [Read more]

Industry Prepackaged Software
Founded 2011
Employees 4,500
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 9EH
Full Company Profile

Financial Performance

In 2024, Evolent Health's revenue was $2.55 billion, an increase of 30.09% compared to the previous year's $1.96 billion. Losses were -$93.45 million, -34.31% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.